Market Cap (In JPY)
13.17 Billion
Revenue (In JPY)
2.48 Billion
Net Income (In JPY)
310.98 Million
Avg. Volume
8872.00
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1213.0-2358.0
- PE
- -
- EPS
- -
- Beta Value
- 0.6
- ISIN
- JP3399640006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Takafumi Shimizu
- Employee Count
- -
- Website
- https://www.stemcell.co.jp
- Ipo Date
- Details
- StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
More Stocks
-
HUBGHub Group, Inc.
HUBG
-
MGRO
-
ALRGRRougier S.A.
ALRGR
-
EXPLEOSOLExpleo Solutions Limited
EXPLEOSOL
-
688575
-
CECO
-
5Y7
-
000755